Zakir Sahul, MD
Interventional Cardiology · Ypsilanti, MINPI 1083659486
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 16 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 7 manufacturers reported payments, led by Kestra Medical Technology Services, Inc. at 41.7% of the total. That places this record below the midpoint for interventional cardiology clinicians in MI, where the typical reported total is $6,857.
Across 16 payments — averaging $25.72 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Kestra Medical Technology Services, Inc.$172
- Edwards Lifesciences$65
- Medtronic$44
- Cordis US CORP.$39
- Cardiovascular Systems Inc.$36
- Abbott$31
- plus $24 from 1 others
Across 38 payments — averaging $7233.21 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Eli Lilly$185K
- Abbott$90K
What the payments were for
- Food & beverage$412100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Kestra Medical Technology Services, Inc. | 4 | $172 |
| Edwards Lifesciences | 2 | $65 |
| Medtronic(2 entities) | 3 | $44 |
| Cordis US CORP. | 2 | $39 |
| Cardiovascular Systems Inc. | 2 | $36 |
| Abbott | 2 | $31 |
| Biosense Webster, Inc. | 1 | $24 |
How this compares
$412 in reported general payments places this provider in the 0th percentile of 187 interventional cardiology providers in Michigan.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 130 | $154,819 |
| Repatha SureclickEvolocumab | 34 | $34,388 |
| XareltoRivaroxaban | 16 | $24,251 |
| Icosapent Ethyl | 11 | $3,041 |
| Atorvastatin Calcium | 160 | $2,912 |
| Metoprolol Succinate | 151 | $2,833 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 57 | $2,191 |
| Isosorbide Mononitrate ErIsosorbide Mononitrate | 85 | $2,114 |
| Metoprolol Tartrate | 120 | $1,073 |
| Bumetanide | 14 | $1,010 |
| Rosuvastatin Calcium | 54 | $978 |
| Ezetimibe | 43 | $813 |
| Nitroglycerin | 55 | $742 |
| Losartan Potassium | 64 | $733 |
| Carvedilol | 44 | $699 |
Paid to pharmacies, not to this prescriber.
Other interventional cardiology in Ypsilanti
- Javier ValleYpsilanti$155K
- Herbert AronowYpsilanti$25K
- Amir KakiDetroit$1.8M
- Tamam MohamadDetroit$960K
- Paul GrossmanAnn Arbor$630K
- Jason RicciPetoskey$594K
- Tim FischellKalamazoo$468K
- Mir BasirDetroit$442K
- Amr AbbasBerkley$416K
- Safwan KassasSaginaw$340K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.